<!DOCTYPE html>
<html lang="en">
<head>
  
  
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    
    
    <link rel="canonical" href="https://jzpero.github.io/mednotes/Critical%20Care/Shock%20and%20Resuscitation/Albumin/">
    <link rel="shortcut icon" href="../../../img/favicon.ico">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0" />
    <title>Albumin - MedNotes</title>
    <link href="../../../css/bootstrap-3.3.7.min.css" rel="stylesheet">
    <link href="../../../css/font-awesome-4.7.0.css" rel="stylesheet">
    <link href="../../../css/base.css" rel="stylesheet">
    <link rel="stylesheet" href="../../../css/highlight.css">
    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
        <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
        <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->

    <script src="../../../js/jquery-3.2.1.min.js"></script>
    <script src="../../../js/bootstrap-3.3.7.min.js"></script>
    <script src="../../../js/highlight.pack.js"></script>
    
    <base target="_top">
    <script>
      var base_url = '../../..';
      var is_top_frame = false;
        
        var pageToc = [
          {title: "Albumin", url: "#_top", children: [
          ]},
          {title: "Critically Ill Patients", url: "#critically-ill-patients", children: [
          ]},
          {title: "Severe Sepsis and Septic Shock", url: "#severe-sepsis-and-septic-shock", children: [
          ]},
          {title: "Decompensated Cirrhosis", url: "#decompensated-cirrhosis", children: [
          ]},
        ];

    </script>
    <script src="../../../js/base.js"></script> 
</head>

<body>
<script>
if (is_top_frame) { $('body').addClass('wm-top-page'); }
</script>



<div class="container-fluid wm-page-content">
  <a name="_top"></a>
    

    
    
      
    

  <div class="row wm-article-nav-buttons" role="navigation" aria-label="navigation">
    
    <div class="wm-article-nav pull-right">
      <a href="../BOX%20Trial%20%282022%29/" class="btn btn-xs btn-default pull-right">
        Next
        <i class="fa fa-chevron-right" aria-hidden="true"></i>
      </a>
      <a href="../BOX%20Trial%20%282022%29/" class="btn btn-xs btn-link">
        BOX (2022)
      </a>
    </div>
    
    <div class="wm-article-nav">
      <a href="../ACLS%20-%20Shockable%20Rhythm/" class="btn btn-xs btn-default pull-left">
        <i class="fa fa-chevron-left" aria-hidden="true"></i>
        Previous</a><a href="../ACLS%20-%20Shockable%20Rhythm/" class="btn btn-xs btn-link">
        ACLS - Shockable Rhythms
      </a>
    </div>
    
  </div>

    

    <h1 id="albumin">Albumin</h1>
<h1 id="critically-ill-patients">Critically Ill Patients</h1>
<ul>
<li>The <strong>SAFE (NEJM 2004)</strong> study randomized ICU patients requiring IV fluids to albumin or saline.<ul>
<li>There were no differences in all-cause mortality.</li>
<li>Albumin was associated with worse outcomes in patients with TBI</li>
<li>There was a non-significant trend towards mortality benefit with albumin use in patients with severe sepsis.</li>
</ul>
</li>
</ul>
<h1 id="severe-sepsis-and-septic-shock">Severe Sepsis and Septic Shock</h1>
<ul>
<li>The <strong>ALBIOS (NEJM 2014)</strong> study randomized patients with severe sepsis to 20% albumin + crystalloid solution vs crystalloids alone.<ul>
<li>Target albumin level was &gt;30 g/L in those in the albumin arm, until ICU discharge or 28 days after randomization</li>
<li>Outcomes: in the first 7 days, the albumin arm had a higher MAP  and a lower net fluid balance. No difference in 28-d mortality, 90-d mortality.</li>
<li>Those treated with albumin had more favorable SOFA subscores and received fewer vasopressors or inotropes.</li>
</ul>
</li>
</ul>
<h1 id="decompensated-cirrhosis">Decompensated Cirrhosis</h1>
<ul>
<li>The <strong>ATTIRE (NEJM 2021)</strong> trial randomized patients with decompensated cirrhosis with serum albumin &lt; 30 g/L to targeted 20% albumin for up to 14d or standard care.<ul>
<li>Target albumin level was â‰¥30 g/L</li>
<li>There was no difference in the primary outcome of new infection, renal dysfunction, or death between days 3-15 after initiation of treatment.</li>
<li>There were more adverse events in the albumin group than in the standard-care group</li>
</ul>
</li>
</ul>

  <br>
    

    
    
      
    

  <div class="row wm-article-nav-buttons" role="navigation" aria-label="navigation">
    
    <div class="wm-article-nav pull-right">
      <a href="../BOX%20Trial%20%282022%29/" class="btn btn-xs btn-default pull-right">
        Next
        <i class="fa fa-chevron-right" aria-hidden="true"></i>
      </a>
      <a href="../BOX%20Trial%20%282022%29/" class="btn btn-xs btn-link">
        BOX (2022)
      </a>
    </div>
    
    <div class="wm-article-nav">
      <a href="../ACLS%20-%20Shockable%20Rhythm/" class="btn btn-xs btn-default pull-left">
        <i class="fa fa-chevron-left" aria-hidden="true"></i>
        Previous</a><a href="../ACLS%20-%20Shockable%20Rhythm/" class="btn btn-xs btn-link">
        ACLS - Shockable Rhythms
      </a>
    </div>
    
  </div>

    <br>
</div>

<footer class="container-fluid wm-page-content">
  <p>Documentation built with <a href="https://www.mkdocs.org/">MkDocs</a> using <a href="https://github.com/gristlabs/mkdocs-windmill">Windmill</a> theme by Grist Labs.</p>
</footer>

</body>
</html>